Epidemiology and clinical features of respiratory syncytial virus (RSV) infection in hospitalized children during the COVID‐19 pandemic in Gorgan, Iran

Abstract

Background and AimsRespiratory syncytial virus (RSV) is a leading cause of acute respiratory infection in infants and young children. Given the altered circulation patterns of respiratory viruses during the coronavirus disease pandemic‐2019 (COVID‐19), the study aimed to evaluate epidemiology and clinical features of RSV infections in hospitalized children during the COVID‐19 pandemic in Gorgan, northeastern Iran. Molecular epidemiology studies on respiratory viral infections are necessary to monitor circulating viruses, disease severity, and clinical symptoms, in addition to early warning of new outbreaks.MethodsOverall, 411 respiratory swab samples from hospitalized children from October 2021 to March 2022 were collected at Taleghani Children's Hospital, Gorgan, Iran. The incidence of RSV, as well as the circulating subgroups and genotypes, were investigated and confirmed using PCR methods. Additionally, all samples tested for severe acute respiratory syndrome‐associated coronavirus 2 (SARS‐CoV‐2) and influenza, and demographic and clinical data were analyzed using SPSS software.ResultsThe share of RSV, SARS‐CoV‐2, and influenza among hospitalized children with acute lower respiratory infections (ALRI) were 27%, 16.5%, and 4.1%, respectively. The RSV subgroup A (genotype ON1) was dominant over subgroup B (genotype BA9), with more severe clinical symptoms. Compared with the prepandemic era there were high numbers of hospitalized SARS‐CoV‐2 positive children and low numbers of other respiratory viruses. Despite this, the prevalence of ALRI‐related RSV‐disease among hospitalized children in our specialized pediatric center was higher than COVID‐19 disease in the same cohort.ConclusionsStudying the epidemiology of respiratory viruses and determining the circulating strains can contribute to effective infection control and treatment strategies.